The VIP2* study is an international, multicenter study of the aging intensive care unit population. The aim is development and validation of a mortality risk score for very old intensive care patients.

The VIP2 study builds on the successful VIP1 study which was published in 2017.

ICU recruitment started in the fall of 2017 and is ongoing and will continue until fall of 2018. Most countries and ICUs are still in the process of aquiring ethical approvals.

Patient recruitment started on May 4th 2018 and will continue through the fall of 2018.
Click here to learn about data entry.

Follow this link below to register your ICU in the study:

Following your ICU registration you'll recieve log in information via email.

Read more about the study the Documents section.

Ethical approval
In many countries ethical approval is required at the country or ICU level and steps should be taken to apply for ethical approval either individually for each ICU or via the national coordinator for your country.

Ethical approval may take some time and this process should be started as soon as possible to allow time for processing.
Please go ahead and register your ICU even though approvals are pending and we will update your ICU record when approvals are in place. If approval ultimately can not be obtained for your ICU/country we will simply release your ICU from the study.

We have opened the datbase for patient data entry but are aware that in many countries ethical approval is still pending and will be for some time.

Follow the project on ResearchGate.

The VIP2 study is endorsed by ESICM.

ClinicalTrials.gov registration

A research conference about VIPs was held 5-6th of June 2018 in Bergen, Norway

For inquiries please contact us.

*The VIP2 study is called POETICS2 in the UK.

243 ICUs

registered per
19-09-2018 23:27

717 patients

included per
19-09-2018 23:27

ICUs per country registered in the VIP2-study

Updated: 19-09-2018 23:27